ZA985498B - 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine - Google Patents

5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine

Info

Publication number
ZA985498B
ZA985498B ZA985498A ZA985498A ZA985498B ZA 985498 B ZA985498 B ZA 985498B ZA 985498 A ZA985498 A ZA 985498A ZA 985498 A ZA985498 A ZA 985498A ZA 985498 B ZA985498 B ZA 985498B
Authority
ZA
South Africa
Prior art keywords
tetrahydropyridine
tetrazol
ethyl
methyl
Prior art date
Application number
ZA985498A
Other languages
English (en)
Inventor
Michael Bech Sommer
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of ZA985498B publication Critical patent/ZA985498B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA985498A 1997-07-01 1998-06-24 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine ZA985498B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
ZA985498B true ZA985498B (en) 1999-01-20

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985498A ZA985498B (en) 1997-07-01 1998-06-24 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine

Country Status (25)

Country Link
EP (1) EP0994869A1 (xx)
JP (1) JP2002507215A (xx)
KR (1) KR20010014297A (xx)
CN (1) CN1261361A (xx)
AR (1) AR013096A1 (xx)
AU (1) AU735751B2 (xx)
BG (1) BG103933A (xx)
BR (1) BR9810331A (xx)
CA (1) CA2293324A1 (xx)
CO (1) CO4940483A1 (xx)
EA (1) EA200000081A1 (xx)
HU (1) HUP0002876A2 (xx)
IL (1) IL133093A0 (xx)
IS (1) IS5278A (xx)
JO (1) JO2031B1 (xx)
MA (1) MA25138A1 (xx)
NO (1) NO996580L (xx)
PE (1) PE116099A1 (xx)
PL (1) PL337184A1 (xx)
SK (1) SK187399A3 (xx)
TN (1) TNSN98120A1 (xx)
TR (1) TR199903283T2 (xx)
UY (2) UY25069A1 (xx)
WO (1) WO1999001448A1 (xx)
ZA (1) ZA985498B (xx)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
TR199800801T2 (xx) * 1995-11-06 1998-08-21 H. Lund-Beck A/S Travmatik beyin yaralanmalar�n�n tedavisi.

Also Published As

Publication number Publication date
PE116099A1 (es) 1999-11-23
JP2002507215A (ja) 2002-03-05
CO4940483A1 (es) 2000-07-24
BG103933A (en) 2000-07-31
CA2293324A1 (en) 1999-01-14
IS5278A (is) 1999-11-30
AR013096A1 (es) 2000-12-13
SK187399A3 (en) 2000-06-12
NO996580D0 (no) 1999-12-30
HUP0002876A2 (hu) 2001-06-28
CN1261361A (zh) 2000-07-26
TR199903283T2 (xx) 2000-06-21
AU735751B2 (en) 2001-07-12
AU8102098A (en) 1999-01-25
NO996580L (no) 1999-12-30
JO2031B1 (en) 1999-05-15
BR9810331A (pt) 2000-09-05
MA25138A1 (fr) 2001-04-02
PL337184A1 (en) 2000-08-14
EP0994869A1 (en) 2000-04-26
UY25069A1 (es) 1998-12-21
WO1999001448A1 (en) 1999-01-14
UY25177A1 (es) 2000-12-29
EA200000081A1 (ru) 2000-08-28
IL133093A0 (en) 2001-03-19
KR20010014297A (ko) 2001-02-26
TNSN98120A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
DE69925845D1 (en) 4-carboxamino-2-subsitutierte-1,2,3,4-tetrahydrochinoline als cetp inhibitoren
DE69920727D1 (en) 4-carboxamino-2-methyl-1,2,3,4-tetrahydrochinoline als cetp inhibitoren
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
GC0000108A (en) 4-Amino substituted-2-substituted-1,2,3,4-tetrahy droquinolines.
ZA977011B (en) Muscarinic antagonists.
ZA97303B (en) Pyrido-fused thienyl- and furanyl-oxazolidinones
HU9800541D0 (en) 1,4-benzothiazepine-1,1-dioxides as hypolipidemic
MXPA02001088A (es) 2-pirazolin-5-onas..
IL113402A0 (en) 3,5 - disubstituted tetrahydrofuran -2- ones
HK1030387A1 (en) Shank fitting structure.
HK1012174A1 (en) Whitening powder.
ZA964473B (en) Endoparasiticidal compositions.
ZA985875B (en) Azetidines.
PL339350A1 (en) 3-(1,2-benzothiazole- or isoxazo-5-yl)-substituted pyrimidines as herbicides
HUP9904622A3 (en) 1,4-di-sustituted piperidines as muscarinic antagonists
ZA987304B (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives.
IL134996A0 (en) 6,11-bridged erythromycin derivatives
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
IL149507A0 (en) 3-(4,5-dihydroisoxazole-5-yl) benzoylpyrazole
GB2322946B (en) Command value decision unit
ZA9810347B (en) Door module.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA985498B (en) 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine
ZA979781B (en) Piperidine derivatives.